{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:59:51Z","timestamp":1776088791656,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T00:00:00Z","timestamp":1670025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T00:00:00Z","timestamp":1670025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00262-022-03339-6","type":"journal-article","created":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T03:03:12Z","timestamp":1670036592000},"page":"1429-1444","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Refurbishment of NK cell effector functions through their receptors by depleting the activity of nTreg cells in Dalton\u2019s Lymphoma-induced tumor microenvironment: an in vitro and in vivo study"],"prefix":"10.1007","volume":"72","author":[{"given":"Munendra Singh","family":"Tomar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishi Kant","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilya V.","family":"Ulasov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Kaushalendra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7621-9477","authenticated-orcid":false,"given":"Arbind","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,3]]},"reference":[{"issue":"6","key":"3339_CR1","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/eji.201344272","volume":"44","author":"M Vitale","year":"2014","unstructured":"Vitale M et al (2014) Effect of tumor cells and tumor microenvironment on NK-cell function. Eur J Immunol 44(6):1582\u20131592","journal-title":"Eur J Immunol"},{"key":"3339_CR2","doi-asserted-by":"publisher","first-page":"6248590","DOI":"10.1155\/2018\/6248590","volume":"2018","author":"B Han","year":"2018","unstructured":"Han B et al (2018) Altered NKp30, NKp46, NKG2D, and DNAM-1 expression on circulating NK cells is associated with tumor progression in human gastric cancer. J Immunol Res 2018:6248590","journal-title":"J Immunol Res"},{"key":"3339_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/1471-2407-9-186","volume":"9","author":"T Garcia-Iglesias","year":"2009","unstructured":"Garcia-Iglesias T et al (2009) Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions. BMC Cancer 9:186","journal-title":"BMC Cancer"},{"issue":"1","key":"3339_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.arcmed.2016.02.001","volume":"47","author":"D Sandoval-Borrego","year":"2016","unstructured":"Sandoval-Borrego D et al (2016) Overexpression of CD158 and NKG2A inhibitory receptors and underexpression of NKG2D and NKp46 activating receptors on NK cells in acute Myeloid Leukemia. Arch Med Res 47(1):55\u201364","journal-title":"Arch Med Res"},{"issue":"1","key":"3339_CR5","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.1038\/s41467-019-13032-5","volume":"10","author":"X Zhang","year":"2019","unstructured":"Zhang X et al (2019) Synergized regulation of NK cell education by NKG2A and specific Ly49 family members. Nat Commun 10(1):5010","journal-title":"Nat Commun"},{"issue":"1","key":"3339_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4049\/jimmunol.1002597","volume":"186","author":"LE Wai","year":"2011","unstructured":"Wai LE et al (2011) Distinct roles for the NK cell-activating receptors in mediating interactions with dendritic cells and tumor cells. J Immunol 186(1):222\u2013229","journal-title":"J Immunol"},{"issue":"1","key":"3339_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/ar1034","volume":"6","author":"AR French","year":"2004","unstructured":"French AR, Yokoyama WM (2004) Natural killer cells and autoimmunity. Arthritis Res Ther 6(1):8\u201314","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3339_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/08820139.2017.1368545","volume":"47","author":"MS Tomar","year":"2018","unstructured":"Tomar MS et al (2018) NK cell effector functions regulation by modulating nTreg cell population during progressive growth of Dalton\u2019s lymphoma in mice. Immunol Invest 47(1):40\u201356","journal-title":"Immunol Invest"},{"issue":"12","key":"3339_CR9","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1002\/eji.201141532","volume":"41","author":"C Bergmann","year":"2011","unstructured":"Bergmann C et al (2011) Human tumor-induced and naturally occurring Treg cells differentially affect NK cells activated by either IL-2 or target cells. Eur J Immunol 41(12):3564\u20133573","journal-title":"Eur J Immunol"},{"issue":"8","key":"3339_CR10","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1084\/jem.20051511","volume":"202","author":"F Ghiringhelli","year":"2005","unstructured":"Ghiringhelli F et al (2005) CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J Exp Med 202(8):1075\u20131085","journal-title":"J Exp Med"},{"issue":"1","key":"3339_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.7150\/jca.5519","volume":"4","author":"A Jewett","year":"2013","unstructured":"Jewett A, Man YG, Tseng HC (2013) Dual functions of natural killer cells in selection and differentiation of stem cells; role in regulation of inflammation and regeneration of tissues. J Cancer 4(1):12\u201324","journal-title":"J Cancer"},{"issue":"1","key":"3339_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1189\/jlb.0606409","volume":"81","author":"N Ralainirina","year":"2007","unstructured":"Ralainirina N et al (2007) Control of NK cell functions by CD4+CD25+ regulatory T cells. J Leukoc Biol 81(1):144\u2013153","journal-title":"J Leukoc Biol"},{"issue":"3","key":"3339_CR13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/nm0307-250","volume":"13","author":"TJ Curiel","year":"2007","unstructured":"Curiel TJ (2007) Regulatory T-cell development: is Foxp3 the decider? Nat Med 13(3):250\u2013253","journal-title":"Nat Med"},{"issue":"1","key":"3339_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/cei.13290","volume":"197","author":"M Attias","year":"2019","unstructured":"Attias M, Al-Aubodah T, Piccirillo CA (2019) Mechanisms of human FoxP3(+) Treg cell development and function in health and disease. Clin Exp Immunol 197(1):36\u201351","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"3339_CR15","first-page":"7661","volume":"8","author":"X Yun","year":"2015","unstructured":"Yun X, Shang Y, Li M (2015) Effect of Lactobacillus salivarius on Th1\/Th2 cytokines and the number of spleen CD4(+) CD25(+) Foxp3(+) Treg in asthma Balb\/c mouse. Int J Clin Exp Pathol 8(7):7661\u20137674","journal-title":"Int J Clin Exp Pathol"},{"key":"3339_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1479-5876-6-19","volume":"6","author":"V Karanikas","year":"2008","unstructured":"Karanikas V et al (2008) Foxp3 expression in human cancer cells. J Transl Med 6:19","journal-title":"J Transl Med"},{"issue":"2","key":"3339_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00262-012-1343-0","volume":"62","author":"M Tongu","year":"2013","unstructured":"Tongu M et al (2013) Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo. Cancer Immunol Immunother 62(2):383\u2013391","journal-title":"Cancer Immunol Immunother"},{"issue":"10","key":"3339_CR18","first-page":"2731","volume":"62","author":"S Man","year":"2002","unstructured":"Man S et al (2002) Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water. Cancer Res 62(10):2731\u20132735","journal-title":"Cancer Res"},{"issue":"7","key":"3339_CR19","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1182\/blood-2004-06-2410","volume":"105","author":"ME Lutsiak","year":"2005","unstructured":"Lutsiak ME et al (2005) Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood 105(7):2862\u20132868","journal-title":"Blood"},{"issue":"8","key":"3339_CR20","doi-asserted-by":"publisher","first-page":"e954471","DOI":"10.4161\/21624011.2014.954471","volume":"3","author":"ZC Ding","year":"2014","unstructured":"Ding ZC, Munn DH, Zhou G (2014) Chemotherapy-induced myeloid suppressor cells and antitumor immunity: The Janus face of chemotherapy in immunomodulation. Oncoimmunology 3(8):e954471","journal-title":"Oncoimmunology"},{"issue":"1\u20133","key":"3339_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12026-009-8139-0","volume":"47","author":"L Luznik","year":"2010","unstructured":"Luznik L, Fuchs EJ (2010) High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation. Immunol Res 47(1\u20133):65\u201377","journal-title":"Immunol Res"},{"issue":"5","key":"3339_CR22","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00262-006-0225-8","volume":"56","author":"F Ghiringhelli","year":"2007","unstructured":"Ghiringhelli F et al (2007) Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients. Cancer Immunol Immunother 56(5):641\u2013648","journal-title":"Cancer Immunol Immunother"},{"key":"3339_CR23","doi-asserted-by":"crossref","unstructured":"Oh E, et al (2019) Erratum: Oh E, et al. Cryopreserved human natural killer cells exhibit potent antitumor efficacy against orthotopic pancreatic cancer through efficient tumor-homing and cytolytic ability (Running Title: Cryopreserved NK Cells Exhibit Antitumor Effect). Cancers 2019, 11, 966. Cancers (Basel), 2020. 12(11).","DOI":"10.3390\/cancers12113255"},{"key":"3339_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fphar.2016.00003","volume":"7","author":"B Choudhury","year":"2016","unstructured":"Choudhury B et al (2016) Anticancer activity of Garcinia morella on T-cell murine lymphoma via apoptotic induction. Front Pharmacol 7:3","journal-title":"Front Pharmacol"},{"key":"3339_CR25","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.biopha.2017.01.044","volume":"88","author":"G Sharma","year":"2017","unstructured":"Sharma G et al (2017) p53 dependent apoptosis and cell cycle delay induced by heteroleptic complexes in human cervical cancer cells. Biomed Pharmacother 88:218\u2013231","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"3339_CR26","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1365-3083.2011.02667.x","volume":"75","author":"R Valiathan","year":"2012","unstructured":"Valiathan R et al (2012) Evaluation of a flow cytometry-based assay for natural killer cell activity in clinical settings. Scand J Immunol 75(4):455\u2013462","journal-title":"Scand J Immunol"},{"issue":"41","key":"3339_CR27","doi-asserted-by":"publisher","first-page":"70431","DOI":"10.18632\/oncotarget.19712","volume":"8","author":"J Lee","year":"2017","unstructured":"Lee J et al (2017) Natural killer cell activity for IFN-gamma production as a supportive diagnostic marker for gastric cancer. Oncotarget 8(41):70431\u201370440","journal-title":"Oncotarget"},{"issue":"5","key":"3339_CR28","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.4049\/jimmunol.1201542","volume":"190","author":"R Tallerico","year":"2013","unstructured":"Tallerico R et al (2013) Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules. J Immunol 190(5):2381\u20132390","journal-title":"J Immunol"},{"issue":"5","key":"3339_CR29","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.tranon.2016.07.003","volume":"9","author":"NG Nieto-Velazquez","year":"2016","unstructured":"Nieto-Velazquez NG et al (2016) Altered expression of natural cytotoxicity receptors and NKG2D on peripheral blood NK cell subsets in breast cancer patients. Transl Oncol 9(5):384\u2013391","journal-title":"Transl Oncol"},{"issue":"46","key":"3339_CR30","doi-asserted-by":"publisher","first-page":"11808","DOI":"10.1073\/pnas.1804931115","volume":"115","author":"L Shi","year":"2018","unstructured":"Shi L et al (2018) Modulation of NKG2D, NKp46, and Ly49C\/I facilitates natural killer cell-mediated control of lung cancer. Proc Natl Acad Sci U S A 115(46):11808\u201311813","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"3339_CR31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1365-3083.2009.02227.x","volume":"69","author":"XJ Wang","year":"2009","unstructured":"Wang XJ et al (2009) Activated T cells inhibit NK cell-mediated tumour rejection. Scand J Immunol 69(4):337\u2013341","journal-title":"Scand J Immunol"},{"issue":"10","key":"3339_CR32","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1084\/jem.20041522","volume":"200","author":"MJ Smyth","year":"2004","unstructured":"Smyth MJ et al (2004) NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer. J Exp Med 200(10):1325\u20131335","journal-title":"J Exp Med"},{"issue":"7","key":"3339_CR33","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.4049\/jimmunol.158.7.3174","volume":"158","author":"M Salcedo","year":"1997","unstructured":"Salcedo M et al (1997) Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I-deficient mice. J Immunol 158(7):3174\u20133180","journal-title":"J Immunol"},{"issue":"5","key":"3339_CR34","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ni1581","volume":"9","author":"LL Lanier","year":"2008","unstructured":"Lanier LL (2008) Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9(5):495\u2013502","journal-title":"Nat Immunol"},{"issue":"1","key":"3339_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3083.2007.02026.x","volume":"67","author":"G Vahlne","year":"2008","unstructured":"Vahlne G et al (2008) IFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells. Scand J Immunol 67(1):1\u201311","journal-title":"Scand J Immunol"},{"issue":"3","key":"3339_CR36","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0952-7915(03)00039-6","volume":"15","author":"LL Lanier","year":"2003","unstructured":"Lanier LL (2003) Natural killer cell receptor signaling. Curr Opin Immunol 15(3):308\u2013314","journal-title":"Curr Opin Immunol"},{"issue":"11","key":"3339_CR37","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1182\/blood-2009-08-238469","volume":"115","author":"C Fauriat","year":"2010","unstructured":"Fauriat C et al (2010) Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 115(11):2167\u20132176","journal-title":"Blood"},{"issue":"10","key":"3339_CR38","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s00262-020-02615-7","volume":"69","author":"PH Feng","year":"2020","unstructured":"Feng PH et al (2020) NKG2D-Fc fusion protein promotes antitumor immunity through the depletion of immunosuppressive cells. Cancer Immunol Immunother 69(10):2147\u20132155","journal-title":"Cancer Immunol Immunother"},{"issue":"9","key":"3339_CR39","doi-asserted-by":"publisher","first-page":"e73952","DOI":"10.1371\/journal.pone.0073952","volume":"8","author":"S Zhou","year":"2013","unstructured":"Zhou S et al (2013) Depletion of CD4+ CD25+ regulatory T cells promotes CCL21-mediated antitumor immunity. PLoS ONE 8(9):e73952","journal-title":"PLoS ONE"},{"issue":"22","key":"3339_CR40","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1158\/1078-0432.CCR-17-0895","volume":"23","author":"M Scurr","year":"2017","unstructured":"Scurr M et al (2017) Low-dose cyclophosphamide induces antitumor T-cell responses, which associate with survival in metastatic colorectal cancer. Clin Cancer Res 23(22):6771\u20136780","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3339_CR41","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00262-018-2288-8","volume":"68","author":"CM Huijts","year":"2019","unstructured":"Huijts CM et al (2019) The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial. Cancer Immunol Immunother 68(3):503\u2013515","journal-title":"Cancer Immunol Immunother"},{"issue":"22","key":"3339_CR42","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015722","volume":"98","author":"X Geng","year":"2019","unstructured":"Geng X et al (2019) CD4+CD25+Foxp3+ regulatory T cells suppress NKG2D-mediated NK cell cytotoxicity in peripheral blood. Medicine (Baltimore) 98(22):e15722","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"3339_CR43","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.molimm.2004.07.034","volume":"42","author":"MJ Smyth","year":"2005","unstructured":"Smyth MJ et al (2005) Activation of NK cell cytotoxicity. Mol Immunol 42(4):501\u2013510","journal-title":"Mol Immunol"},{"key":"3339_CR44","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","volume":"19","author":"A Moretta","year":"2001","unstructured":"Moretta A et al (2001) Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19:197\u2013223","journal-title":"Annu Rev Immunol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-022-03339-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-022-03339-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-022-03339-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T12:19:22Z","timestamp":1701519562000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-022-03339-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,3]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["3339"],"URL":"https:\/\/doi.org\/10.1007\/s00262-022-03339-6","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,3]]},"assertion":[{"value":"3 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research is the part of PhD work of MST. PI had received financial support from UGC, New Delhi, and DST New Delhi. All other co-authors have contributed in performing the experimental design, writing, and critically reviewing the manuscript. On behalf of all the authors, it is declared that there is no any potential conflict of interest and all have given their consent for the publication of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal experiments were performed according to the guidelines given by Institution Animal Ethical Committee (IAEC), Department of Zoology, Banaras Hindu University, Varanasi, India.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}